140 related articles for article (PubMed ID: 37815579)
41. AKR1B10 confers resistance to radiotherapy via FFA/TLR4/NF-κB axis in nasopharyngeal carcinoma.
Liu X; Hu Z; Qu J; Li J; Gong K; Wang L; Jiang J; Li X; He R; Duan L; Luo W; Xia C; Luo D
Int J Biol Sci; 2021; 17(3):756-767. PubMed ID: 33767586
[TBL] [Abstract][Full Text] [Related]
42. Fear of Cancer Recurrence and Coping Strategies among Prostate Cancer Survivors: A Qualitative Study.
Mardani A; Farahani MA; Khachian A; Vaismoradi M
Curr Oncol; 2023 Jul; 30(7):6720-6733. PubMed ID: 37504353
[TBL] [Abstract][Full Text] [Related]
43. Beyond cancer: a reflection on the narratives of nasopharyngeal carcinoma patients in Nagaland.
Imchen T
Support Care Cancer; 2021 Oct; 29(10):5839-5846. PubMed ID: 33754197
[TBL] [Abstract][Full Text] [Related]
44. Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients.
Yang S; Chen J; Guo Y; Lin H; Zhang Z; Feng G; Hao Y; Cheng J; Liang P; Chen K; Wu H; Li Y
Int J Oncol; 2012 May; 40(5):1590-600. PubMed ID: 22267178
[TBL] [Abstract][Full Text] [Related]
45. MR-based synthetic CT image for intensity-modulated proton treatment planning of nasopharyngeal carcinoma patients.
Chen S; Peng Y; Qin A; Liu Y; Zhao C; Deng X; Deraniyagala R; Stevens C; Ding X
Acta Oncol; 2022 Nov; 61(11):1417-1424. PubMed ID: 36305424
[TBL] [Abstract][Full Text] [Related]
46. The experience of hospital-related fears of 4- to 6-year-old children.
Salmela M; Aronen ET; Salanterä S
Child Care Health Dev; 2011 Sep; 37(5):719-26. PubMed ID: 21143264
[TBL] [Abstract][Full Text] [Related]
47. Proton therapy for nasopharyngeal carcinoma.
Holliday EB; Frank SJ
Chin Clin Oncol; 2016 Apr; 5(2):25. PubMed ID: 27121885
[TBL] [Abstract][Full Text] [Related]
48. Risk of hypothyroidism among patients with nasopharyngeal carcinoma treated with radiation therapy: A Population-Based Cohort Study.
Fan CY; Lin CS; Chao HL; Huang WY; Su YF; Lin KT; Tsai IJ; Kao CH
Radiother Oncol; 2017 Jun; 123(3):394-400. PubMed ID: 28532605
[TBL] [Abstract][Full Text] [Related]
49. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.
Rittenmeyer L; Huffman D; Alagna M; Moore E
JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798
[TBL] [Abstract][Full Text] [Related]
50. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
[TBL] [Abstract][Full Text] [Related]
51. Long-term clinical outcome in nasopharyngeal carcinoma patients with post-radiation persistently detectable plasma EBV DNA.
Wang WY; Lin TY; Twu CW; Tsou HH; Lin PJ; Liu YC; Huang JW; Hsieh HY; Lin JC
Oncotarget; 2016 Jul; 7(27):42608-42616. PubMed ID: 27191654
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.
Li WF; Zhang Y; Huang XB; Du XJ; Tang LL; Chen L; Peng H; Guo R; Sun Y; Ma J
Chin J Cancer; 2017 Nov; 36(1):87. PubMed ID: 29116021
[TBL] [Abstract][Full Text] [Related]
53. The impact of time factors on overall survival in patients with nasopharyngeal carcinoma: a population-based study.
Chen PC; Liu WS; Huang WL; Wu CJ; Yang CC; Lee CC
Radiat Oncol; 2016 Apr; 11():62. PubMed ID: 27117713
[TBL] [Abstract][Full Text] [Related]
54. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
Luo Y; Qin Y; Lang J
Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
[TBL] [Abstract][Full Text] [Related]
55. Microbial etiology, susceptibility profile of postradiation nasopharyngeal necrosis patients with nasopharyngeal carcinoma.
Wang L; Yang J; Peng SY; Li GQ; Tu ZW
Cancer Radiother; 2020 Apr; 24(2):93-98. PubMed ID: 32057645
[TBL] [Abstract][Full Text] [Related]
56. The impact of target dosimetry on patients' locoregional recurrence in nasopharyngeal carcinoma: A propensity score-matched analysis.
Wang J; Qing G; Ou X; Hu W; Hu C; Zhang Z
Radiother Oncol; 2019 Dec; 141():67-71. PubMed ID: 31547944
[TBL] [Abstract][Full Text] [Related]
57. Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma.
Dionisi F; Croci S; Giacomelli I; Cianchetti M; Caldara A; Bertolin M; Vanoni V; Pertile R; Widesott L; Farace P; Schwarz M; Amichetti M
Acta Oncol; 2019 Sep; 58(9):1238-1245. PubMed ID: 31155998
[No Abstract] [Full Text] [Related]
58. Fear of progression in patients 6 months after cancer rehabilitation-a- validation study of the fear of progression questionnaire FoP-Q-12.
Hinz A; Mehnert A; Ernst J; Herschbach P; Schulte T
Support Care Cancer; 2015 Jun; 23(6):1579-87. PubMed ID: 25412727
[TBL] [Abstract][Full Text] [Related]
59. Exploring the Experience of Nurses in Providing Care to Patients With COVID-19: A Qualitative Study.
Shahoei R; Nemati SM; Valiee S
J Nurs Res; 2022 Aug; 30(4):e217. PubMed ID: 35576060
[TBL] [Abstract][Full Text] [Related]
60. Nasopharyngeal carcinoma in children and adolescents in an endemic area: a report of 185 cases.
Yan Z; Xia L; Huang Y; Chen P; Jiang L; Zhang B
Int J Pediatr Otorhinolaryngol; 2013 Sep; 77(9):1454-60. PubMed ID: 23830224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
